Please assess the completion status of the following clinical trial:

Trial Title: Doxycycline to Treat Mansonella Perstans Infection in Patients With and Without Lymphatic Filariasis

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: None
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
* INCLUSION CRITERIA - SCREENING:~Age 14 to 65.~Both genders.~Not pregnant or breastfeeding by history.~EXCLUSION CRITERIA - SCREENING:~Non-volunteers.~Age less than 14 or greater than 65.~Pregnant or breastfeeding by history.~INCLUSION CRITERIA - TREATMENT:~Age 14 to 65 years.~Men and non-pregnant or breastfeeding women.~EXCLUSION CRITERIA - TREATMENT:~Non-volunteers.~Age less than 14 or greater than 65.~Pregnancy or breast-feeding.~Hgb less than or equal to 10 g/dl.~Cr greater than 1.4/100 ml.~ALT greater than 45 U or bilirubin greater than 1.5.~Weight less than 40 kg.~Heavy alcohol use (more than 1 beer or other alcohol-containing drink/day).~Temperature greater than 37.5C or other serious medical illnesses.~History of allergy to doxycycline or other tetracyclines.~History of HIV infection or other immunocompromised state.

- Gender: ALL
- Minimum Age: 14 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).